Growth Strategies at GlaxoSmithKline and AstraZeneca; a Comparison

Number of Pages 14

This 14 page paper examines the way in which two well-known pharmaceutical companies are pursuing growth. GlaxoSmithKline has a strategy concentrating on supporting existing and developing new drugs which focuses on organic growth, whereas AstraZeneca has a strategy that focuses on the acquisition of small bioscience firms. The paper discusses the way in which the strategies may have been developed and the potential reasons for the differences in the approaches of the two companies. The bibliography cites 15 sources.


File: TS14_TEglaxgro.rtf


Send me this paper »

« Back to Topic Listings

Copyright © 1994-2025 The Paper Store Enterprises, Inc. & Research Papers Online. All rights reserved.